Subscribe To
Taysha gene therapies to host virtual r&d day on lead clinical investigational programs tsha-120 in giant axonal neuropathy (gan) and tsha-102 in rett syndrome
Virtual R&D Day featuring collaborator Salman Bhai, MD, and Taysha’s leadership team at 10:00 AM ET on June 28, 2023 Company to provide update on ne...
June 15, 2023, 12:00 pm
Surfing the waves with gregor horvat: dxy, eurusd, audusd, xagusd, wti, usdnok & more!
In today’s advanced ElliottWave analysis, Gregor dives into the five most interesting opportunities for the week ahead! Watch how he ...
June 14, 2023, 1:06 pm
Japan quarterly business sentiment index survey, q2 2023. large manufacturing index -0.4%
The Business Sentiment Index (BSI) survey is conducted by the Ministry of Finance and the Economic and Social Research Institute (a part of Japan's Ca...
June 12, 2023, 11:52 pm
Usd/jpy technical analysis: strong bullish momentum
(MENAFN- Daily Forex) In recent technical analyses, amid a strong and sharp bullish momentum for the us...
June 1, 2023, 11:00 am
Silver range resources says work is complete at tonto del pueblo
Silver Range Resources Ltd (TSX-V:SNG, OTC:SLRRF) told investors it is awaiting analytical results from the recently-completed exploration program at ...
May 31, 2023, 12:11 pm
Surfing the waves with gregor horvat: dxy, spx500, dax, eurusd, nzdusd, wti & more!
In today’s advanced ElliottWave analysis, Gregor dives into the five most interesting opportunities for the week ahead! Watch how he ...
May 24, 2023, 12:41 pm
Orbex: surfing the waves with gregor horvat @grega horvat elliott wave analysis
In today’s advanced ElliottWave analysis, Gregor dives into the five most interesting opportunities for the week ahead! Watch how he ...
May 17, 2023, 11:51 am
Surfing the waves with gregor horvat: gbpusd, eurgbp, eurusd, audusd, usdjpy, xagusd & more
In today’s advanced ElliottWave analysis, Gregor dives into the five most interesting opportunities for the week ahead! Watch how he ...
May 12, 2023, 11:50 am
Veru reports fiscal 2023 second quarter financial results
Agreement reached with FDA on confirmatory Phase 3 clinical trial design for sabizabulin treatment of hospitalized COVID-19 adult patients at high ris...
May 11, 2023, 10:30 am
Acwa spring conference explores top california water issues
SACRAMENTO, Calif., May 04, 2023 (GLOBE NEWSWIRE) — The Association of California Water Agencies (ACWA) Spring Conference & Expo May 10-11 will draw...
May 4, 2023, 8:59 pm
Verona pharma to present expanded analyses of positive phase 3 enhance studies in copd in multiple presentations at ats 2023
12 Abstracts and one Symposium further support potential of ensifentrine, a first-in-class, selective, dual inhibitor of PDE3 and PDE4...
May 2, 2023, 2:00 am
Apellis presents phase 3 functional analyses of syfovre™ (pegcetacoplan injection) for geographic atrophy
Showed visual function and quality-of-life benefits in patients with extrafoveal lesions Slowed the loss of retinal pigmented epithelial and photorece...
April 23, 2023, 10:05 pm
Surfing the waves with gregor horvat: eurusd, gbpusd, wti, usdmxn, cadjpy, xauusd
In today’s advanced ElliottWave analysis, Gregor dives into the five most interesting opportunities for the week ahead! Watch how he ...
April 19, 2023, 11:46 am
Why enphase energy stock blasted higher today
Two fresh analyses of the producer of energy industry components brought on the bull run. One prognosti...
April 13, 2023, 5:54 pm
Surfing the waves with gregor horvat: spx500, eurusd, gbpusd, nzdusd, wti, usdnok & more!
In today’s advanced #ElliottWave analysis, Gregor dives into the five most interesting opportunities for the week ahead! Watch how he ...
April 13, 2023, 11:46 am
Tonix pharmaceuticals expedites fibromyalgia and chronic migraine programs
Streamlining Phase 3 Fibromyalgia and Phase 2 Chronic Migraine Trials by Eliminating Interim analyses T...
April 13, 2023, 11:00 am
Apple: the ecosystem and the largest subscription company in the world
As one of the most popular companies in the world, investors in Apple need to look behind the flux of contradicting news and ...
April 12, 2023, 4:18 am
Additional detailed analyses from phase 2 study 201 of lecanemab published as three papers in peer-reviewed journals
TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (...
March 30, 2023, 11:30 pm
Eisai presented new analyses of aria and qol on lecanemab in clarity ad at the ad/pd™ 2023 annual meeting
TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (...
March 30, 2023, 11:30 pm
Eisai to present research from oncology portfolio at the society of gynecologic oncology (sgo) 2023 annual meeting on women's cancer
Study Findings in Patients with Recurrent or Advanced Endometrial Carcinoma Who Were Rechallenged With Platinum Chemotherapy Will Be Featured in an Or...
March 23, 2023, 8:08 am